
CAS 1046447-90-8
:Formel:C11H19N5
InChl:InChI=1S/C11H19N5/c1-7(2)9-5-10(15-11(13)14-9)16-4-3-8(12)6-16/h5,7-8H,3-4,6,12H2,1-2H3,(H2,13,14,15)/t8-/m1/s1
InChI Key:COOGVHJHSCBOQT-MRVPVSSYSA-N
SMILES:CC(C)C1=CC(=NC(=N1)N)N2CC[C@H](C2)N
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
5 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
JNJ-39758979
CAS:JNJ-39758979: selective H4 receptor antagonist, Kis 12.5/5.3/25 nM (human/mouse/monkey), blocks histamine cAMP inhibition (pA2 7.9).Formel:C11H19N5Reinheit:98.33% - 99.62%Farbe und Form:SolidMolekulargewicht:221.3021JNJ-39758979
CAS:(R)-4-(3-Aminopyrrolidin-1-yl)-6-isopropylpyrimidin-2-amineFormel:C11H19N5Reinheit:98%Molekulargewicht:221.3JNJ 39758979 TFA Salt
CAS:Kontrolliertes ProduktApplications JNJ 39758979, is a selective, high-affinity histamine H4 receptor antagonist with a Ki of 12.5 nM.
References Savall, B. M. et al.: J Med Chem. 2014 Mar 27;57(6):2429-39;Formel:C11H19N5·xC2HF3O2Farbe und Form:NeatMolekulargewicht:335.33JNJ 39758979
CAS:JNJ 39758979 is a small molecule compound, which is a selective antagonist of the P2X7 receptor. This receptor is a purinergic ligand-gated ion channel sourced from human and mammalian cell lines, prominent in neurobiological and immunological tissues. The mode of action involves the inhibition of the P2X7 receptor, which plays a crucial role in inflammatory processes and cell death signaling pathways. By blocking this receptor, JNJ 39758979 reduces the release of pro-inflammatory cytokines, thus modulating neuroinflammation.Formel:C11H19N5Reinheit:Min. 95%Molekulargewicht:221.3 g/mol





